Back

Human papillomavirus type 16 circular RNA is barely detectable for the claimed transformation activity

Yu, L.; Zheng, Z.-M.

2021-09-23 cancer biology
10.1101/2021.09.22.449294 bioRxiv
Show abstract

The human papillomavirus type 16 (HPV16) E7 oncoprotein plays an essential role in cervical carcinogenesis and is encoded predominantly by a viral E6*I mRNA through alternative RNA splicing of a p97 promoter-transcribed bicistronic E6E7 pre-mRNA. Recently, Zhao et al. detected the HPV16 circular RNA circE7, which is generated aberrantly through backsplicing of the E6E7 pre-mRNA from two HPV16-positive cervical cancer cell lines, CaSki and SiHa. Based on their findings that HPV16 E7 was translated from circE7 and knockdown of circE7 in CaSki cells led to reduction of E7 oncoprotein, cell proliferation, and xenograft tumor formation, the authors claimed that circE7 is functionally important in cell transformation. We believe, however, that the reported circE7 function is overstated. We found that circE7 in CaSki cells is only 0.4 copy per cell and determine that the claimed circE7 function in the published report was resulted from off-targeting viral E7 linear mRNAs by their circE7 small interfering RNAs.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 14%
12.6%
Similar papers in this journal
2
Cell Reports
○ 1498 papers in training set
Top 5%
6.3%
Similar papers in this journal
3
iScience
○ 1154 papers in training set
Top 2%
5.6%
Similar papers in this journal
4
Nucleic Acids Research
◐ 1281 papers in training set
Top 3%
5.6%
Similar papers in this journal
5
Scientific Reports
○ 3612 papers in training set
Top 15%
5.5%
Similar papers in this journal
6
eLife
● 5828 papers in training set
Top 27%
4.4%
7
Communications Biology
○ 993 papers in training set
Top 4%
3.5%
8
Science Advances
● 1243 papers in training set
Top 13%
2.8%
9
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 21%
2.4%
10
RNA Biology
○ 78 papers in training set
Top 0.5%
2.4%
50% of probability mass above
11
NAR Cancer
◐ 37 papers in training set
Top 0.2%
2.4%
12
Molecular Therapy - Nucleic Acids
○ 25 papers in training set
Top 0.2%
2.0%
13
Journal of Virology
● 499 papers in training set
Top 2%
1.7%
14
Med
○ 39 papers in training set
Top 0.2%
1.7%
15
npj Genomic Medicine
○ 36 papers in training set
Top 0.3%
1.7%
16
mBio
● 833 papers in training set
Top 7%
1.7%
17
Molecular Therapy - Methods & Clinical Development
○ 38 papers in training set
Top 0.4%
1.7%
18
Molecular Cancer
○ 16 papers in training set
Top 0.1%
1.7%
19
Gut
● 40 papers in training set
Top 0.5%
1.5%
20
Developmental Cell
○ 196 papers in training set
Top 3%
1.3%
21
Nature
○ 645 papers in training set
Top 8%
1.1%
22
The CRISPR Journal
○ 39 papers in training set
Top 0.3%
1.1%
23
Molecular Therapy Oncology
○ 10 papers in training set
Top 0.1%
1.0%
24
Science
● 477 papers in training set
Top 8%
1.0%
25
PLOS Pathogens
● 820 papers in training set
Top 8%
1.0%
26
Mobile DNA
○ 31 papers in training set
Top 0.2%
1.0%
27
Molecular Therapy
○ 81 papers in training set
Top 2%
0.9%
28
Molecular Cell
○ 350 papers in training set
Top 5%
0.9%
29
Nature Genetics
○ 286 papers in training set
Top 5%
0.9%
30
Genome Biology
○ 637 papers in training set
Top 9%
0.9%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.